TSXV: RLV FRA: 6BX THIS DOCUMENT HAS BEEN PREPARED BY RELEVIUM - - PowerPoint PPT Presentation

tsxv rlv fra 6bx
SMART_READER_LITE
LIVE PREVIEW

TSXV: RLV FRA: 6BX THIS DOCUMENT HAS BEEN PREPARED BY RELEVIUM - - PowerPoint PPT Presentation

Investing in Active Lifestyles & Healthy Living April 20 & 21, 2016 TSXV: RLV FRA: 6BX THIS DOCUMENT HAS BEEN PREPARED BY RELEVIUM TECHNOLOGIES INC. (THE COMPANY) SOLELY FOR INFORMATION PURPOSES. THIS DOCUMENT DOES NOT CONSTITUTE


slide-1
SLIDE 1

TSXV: RLV ● FRA: 6BX

Investing in Active Lifestyles & Healthy Living

April 20 & 21, 2016

slide-2
SLIDE 2

THIS DOCUMENT HAS BEEN PREPARED BY RELEVIUM TECHNOLOGIES INC. (THE “COMPANY”) SOLELY FOR INFORMATION PURPOSES. THIS DOCUMENT DOES NOT CONSTITUTE AN OFFERING DOCUMENT. THIS DOCUMENT IS THE SOLE RESPONSIBILITY OF THE COMPANY. INFORMATION CONTAINED HEREIN DOES NOT PURPORT TO BE COMPLETE AND IS SUBJECT TO CERTAIN QUALIFICATIONS AND ASSUMPTIONS AND SHOULD NOT BE RELIED UPON FOR THE PURPOSE OF MAKING AN INVESTMENT IN THE COMPANY’S SECURITIES OR ENTERING INTO ANY TRANSACTION IN RELATION THEREWITH. THE INFORMATION AND OPINIONS CONTAINED IN THIS DOCUMENT ARE PROVIDED AS AT THE DATE HEREOF AND ARE SUBJECT TO CHANGE WITHOUT NOTICE AND, IN FURNISHING THIS DOCUMENT, THE COMPANY DOES NOT UNDERTAKE OR AGREE TO ANY OBLIGATION TO PROVIDE RECIPIENTS WITH ACCESS TO ANY ADDITIONAL INFORMATION OR TO UPDATE OR CORRECT THE

  • DOCUMENT. THIS DOCUMENT, NOR HAS IT REVIEWED THIS DOCUMENT.

FORWARD LOOKING INFORMATION CERTAIN OF THE INFORMATION CONTAINED IN THIS PRESENTATION MAY CONTAIN “FORWARD-LOOKING INFORMATION”. FORWARD-LOOKING INFORMATION AND STATEMENTS MAY INCLUDE, AMONG OTHERS, STATEMENTS REGARDING THE FUTURE PLANS, COSTS, OBJECTIVES OR PERFORMANCE OF THE COMPANY, OR THE ASSUMPTIONS UNDERLYING ANY OF THE FOREGOING. IN THIS PRESENTATION, WORDS SUCH AS “MAY”, “WOULD”, “COULD”, “WILL”, “LIKELY”, “BELIEVE”, “EXPECT”, “ANTICIPATE”, “INTEND”, “PLAN”, “ESTIMATE” AND SIMILAR WORDS AND THE NEGATIVE FORM THEREOF ARE USED TO IDENTIFY FORWARD-LOOKING STATEMENTS. FORWARD-LOOKING STATEMENTS SHOULD NOT BE READ AS GUARANTEES OF FUTURE PERFORMANCE OR RESULTS, AND WILL NOT NECESSARILY BE ACCURATE INDICATIONS OF WHETHER, OR THE TIMES AT OR BY WHICH, SUCH FUTURE PERFORMANCE WILL BE ACHIEVED. FORWARD-LOOKING STATEMENTS AND INFORMATION ARE BASED ON INFORMATION AVAILABLE AT THE TIME AND/OR MANAGEMENT’S GOOD-FAITH BELIEF WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO KNOWN OR UNKNOWN RISKS, UNCERTAINTIES, ASSUMPTIONS AND OTHER UNPREDICTABLE FACTORS, MANY OF WHICH ARE BEYOND THE COMPANY’S CONTROL. THE COMPANY DOES NOT INTEND, NOR DOES THE COMPANY UNDERTAKE ANY OBLIGATION, TO UPDATE OR REVISE ANY FORWARD-LOOKING INFORMATION OR STATEMENTS CONTAINED IN THIS PRESENTATION TO REFLECT SUBSEQUENT INFORMATION, EVENTS OR CIRCUMSTANCES OR OTHERWISE, EXCEPT IF REQUIRED BY APPLICABLE LAWS.

slide-3
SLIDE 3

About our Company ABOUT US

slide-4
SLIDE 4

ABOUT US

“It is the Mission of Relevium Technologies to invest in Knowledge, Products and Services in the Health and Wellness Space, with particular focus on Pain Management, Quick Recovery and Optimal

  • Performance. We create value by consolidating unique products

and services for our customers: the progressive health and wellness consumers”

TSXV:RLV ● FRA:6BX

slide-5
SLIDE 5

ABOUT US

Investing in Active Lifestyles & Healthy Living

Pain avoidance is one of the most important drivers of consumer behavior worldwide. The market for pain relief is estimated to be about $39 billion in and it is expected to reach $41.5 billion in 2017 with a compound annual growth of over 5%*. The primary focus of Relevium in this vertical segment is on wearable devices that reduce musculoskeletal pain caused by injuries or mechanical dysfunction.

PAIN MANAGEMENT

TSXV:RLV ● FRA:6BX

TSXV:RLV ● FRA:6BX

*http://www.bccresearch.com/market-research/healthcare/pain-management-drugs-devices-hlc026d.html

slide-6
SLIDE 6

ABOUT US

Musculoskeletal injuries such as sprains and strains are among the most common and costly burdens to the medical system and workforce. Direct costs (medical expenses) related to injuries are estimated at $190 billion per year and indirect costs (loss in wages) $120 billion per year. The Integrated Benefits Institute suggest that for every 100 employees the costs to companies amounts to $103,000 per year.* The primary focus of Relevium in this vertical segment is on wearable technologies that reduce recovery times in treating musculoskeletal injuries.

RECOVERY

Investing in Active Lifestyles & Healthy Living

TSXV:RLV ● FRA:6BX

*http://www.theworkfoundation.com/DownloadPublication/Report/385_White%20paper%20- %20Musculoskeletal%20disorders%20workforce%20health%20and%20productivity%20in%20the%20USA%20final.pdf

slide-7
SLIDE 7

ABOUT US

Traditionally under the global sports apparel market and encompassing over $135 billion of business in 2012, Performance has widened in scope to include Nutrition and Mind. Driven by a growing fitness consciousness, living better and longer the market for performance enhancement is expected to drive market growth exponentially. The primary focus of Relevium in this vertical segment is on Nutraceuticals and Wearables that enhance

  • verall

performance and reduce recovery time.

PERFORMANCE

Investing in Active Lifestyles & Healthy Living

TSXV:RLV ● FRA:6BX

slide-8
SLIDE 8

About our Company LEADERSHIP TEAM

slide-9
SLIDE 9

LEADERSHIP TEAM

Leena Lakdawala

Director and CEO

Leena Lakdawala is a senior executive with 22 years’ experience in the manufacturing and consumer product sector. Leena has served in several senior managerial roles in private and publicly held corporations, including Director of Administration, Director of Marketing, Vice-President of Operations and most recently Executive Vice-President. Leena serves on the board of several privately held companies and serves as an advisor to an early stage business venture. Leena is a graduate Executive MBA from Queens School of Business.

Andre Godin

Director and Chairman

Andre Godin is currently Executive Vice-President & Chief Financial Officer at IntelGenx and has more than 25 years’ experience in the Biotech-Pharma industry. He has a strong background in Capital Markets, Finance and Operations. Mr. Godin held several high level positions as CEO, CFO and Vice- President of pharmaceutical and nutraceutical Companies. Mr. Godin is a member of the Canadian Chartered Professional Accountants and the Canadian Institute of Chartered Accountants. He holds a Bachelor of Business Administration degree from Université du Québec à Montreal.

TSXV:RLV ● FRA:6BX

slide-10
SLIDE 10

LEADERSHIP TEAM

Kristine Dorward

Director

Kristine is Director of Marketing and Business Development at Prometic Life Sciences, joining the

  • rganization in 2014. Having worked in the pharmaceutical and biotechnology industry for more than 17

years, Kristine has held senior positions in licensing, acquisitions, marketing and sales with geographical scope encompassing both North American and global markets. Acting in strategic leadership roles, Kristine has contributed to the successful launch of products in multiple therapeutic areas and has completed numerous due diligence evaluations as part of pipeline planning and expansion efforts to drive corporate growth. Kristine holds an MBA, BSc, CLP designation with CVA credential in progress. Michel Timperio

Director

Michel currently holds the position of Head of Strategic Development at Neptune. He has been employed by Neptune since 2010, but was a member of the Board of Directors from 2000 to 2008. Mr. Timperio has many years of experience in sales. He obtained his Bachelor of Commerce at Concordia University in Montreal, Quebec. With a natural entrepreneurial character, he launched his own distributing business. Many years later, Mr. Timperio built a start-up venture in residential construction from 2001–2010. He has worked for large corporations, including Armstrong World Industries and Reichhold Chemicals, where he held senior management business development positions. Mr. Timperio has also retained a political career for six years.

TSXV:RLV ● FRA:6BX

slide-11
SLIDE 11

LEADERSHIP TEAM

Ted Zablotsky, MD

Director Ted Zablotsky, MD is co-founder and co-inventor of the US Patent acquired by the Company as part of the qualifying transaction of August 2015. Dr. Zablotsky has pioneered research and documentation of the effects of bio-magnetism on the body since 1985. A noted author and speaker, Dr. Zablotsky has been a driving force behind the clinical development, research and regulatory registrations that established the credibility of magnetic therapy. Dr. Zablotsky serves on the board of the Jewish Federation of Greater Hartford. Aurelio Useche MBA. CPA. CMA. ICD.D Providing guidance and support over the M&A activities of the company, Mr. Useche leverages over 20 years of senior management experience in private and publicly traded corporations including manufacturing, mining exploration and consumer products. Aurelio serves on the board of several private and public companies and holds an executive MBA from Queens School of Business he holds a CPA-CMA accreditation and is also a graduate of the Directors Program from the Rotman School of Business.

TSXV:RLV ● FRA:6BX

slide-12
SLIDE 12

ADVISORY BOARD

Jay A. Kiss, N.D Providing guidance and support over the pain management and injury recovery segment of the business, Jay A. Kiss is the founder of SPC Physio in 1996 and as a Sports Therapist, Jay has successfully treated, trained and rehabilitated numerous world class, Olympic and professional athletes. Jay co- developed and put in place a unique system called F.I.T.T.S, the Flexible Integrated Therapy and Training

  • System. The F.I.T.T.S philosophy encompasses several cutting edge manual therapy, evaluation and

training techniques which has become his clinic’s winning formula. Enrique Fidalgo, BSPC Providing guidance and support over the sports performance segment of the business, Enrique Fidalgo is a trained Functional Movement Specialist formally trained at the University of Miami and Professional Sports Coach (BSpC), Swimming Coach, CSCS, TSAC-F. In addition to his training and athletics coaching career, Enrique worked for various non-for-profit organizations helping build national and international community centers in the goal of providing opportunities for underprivileged individuals to attain academic formations and participate in sports.

TSXV:RLV ● FRA:6BX

slide-13
SLIDE 13

About our Company THE OPPORTUNITY

slide-14
SLIDE 14

THE OPPORTUNITY

RECOVERY PERFORMANCE

TSXV:RLV ● FRA:6BX

CORPORATE STRATEGY for 2016-2017:

Establish distribution with carefully selected retailers

B&M Distribution

Build a unique Physiotherapy and Wellness model and consolidate the market

Wellness Clinics

Sourcing the best and latest products and technologies

Source New Products

Building a solid online base for critical mass and branding

Acquire E-Retail Assets

slide-15
SLIDE 15

THE OPPORTUNITY

RECOVERY PERFORMANCE

TSXV:RLV ● FRA:6BX Products

  • Acquire innovative technologies and products

for Pain, Recovery and Performance “at source”

  • Build distribution and branding capabilities

through acquisition of E-Retail assets

  • Establish brick and mortar distribution

Services

  • Develop a comprehensive and unique

Physiotherapy and Wellness system under a single brand

  • Invest in leading edge technology
  • Consolidate this space with Relevium Wellness

Clinics

* https://www.internetretailer.com/2016/01/29/online-sales-will-reach-523-billion-2020-us

Investing in Active Lifestyles & Healthy Living

slide-16
SLIDE 16

THE OPPORTUNITY

RECOVERY PERFORMANCE

TSXV:RLV ● FRA:6BX Relevium is building a pipeline of cash positive E-Retail assets in the US and Europe in order to build distribution power and brand recognition

Initial targets for 2016 include: Nutraceuticals: Targeting niche formulations aimed at the Recovery and Performance markets. Pain Management: Targeting successful e-retailers with a loyal and motivated customer base looking for pain relief products

* https://www.internetretailer.com/2016/01/29/online-sales-will-reach-523-billion-2020-us

CREATING CRITICAL MASS THROUGH ONLINE RETAIL: Online retail in the United States are expected to reach $523 billion in the next five years, up 56% from $335 billion in 2015 and mobile devices are expected to be a key driver in that growth*

Investing in Active Lifestyles & Healthy Living

slide-17
SLIDE 17

THE OPPORTUNITY

RECOVERY PERFORMANCE

TSXV:RLV ● FRA:6BX Relevium has identified an Nutraceutical E-Retailer focused on the area of Cognitive and Brain Performance.

Revenues/Profits About $1.7 Million in revenues arising from two SKUs and net profits of approximately $400K Strategy: Ramp-up revenues by (1) Expanding the number of SKUs in Cognitive Functioning , Injury Recovery and Physical Performance, (2) Improve overall selling and traffic by

  • ptimizing web marketing and using multiple channels and (3)

Introduce distribution to brick and mortar retailers.

* https://www.internetretailer.com/2016/01/29/online-sales-will-reach-523-billion-2020-us

NUTRACEUTICAL E-RETAIL: Online retail in the United States are expected to reach $523 billion in the next five years, up 56% from $335 billion in 2015 and mobile devices are expected to be a key driver in that growth*

Investing in Active Lifestyles & Healthy Living

slide-18
SLIDE 18

THE OPPORTUNITY

RECOVERY PERFORMANCE

TSXV:RLV ● FRA:6BX Relevium has identified a European E-Retailer that currently sells a number of successful proprietary back pain products under a recognized brand

Revenues/Profits About $10 Million in revenues arising from about eight proprietary SKUs and net profits of approximately 30%. Strategy: Leverage the company’s success in delivering pain management products by expanding the number of SKUs by introducing other proprietary products including magnetic back

  • supports. Additionally, expand to North America.

*http://www.arrowheadpublishers.com/index.php/market-research-studies/76-the-global-pain-therapeutics-market-4th-edition-market-trends-a-rad-insights

BACK PAIN E-RETAIL: Globally, 1.5 billion people suffer from moderate to severe chronic pain. Pain is the leading cause of disability in the US, affecting 116 million adults*

Investing in Active Lifestyles & Healthy Living

slide-19
SLIDE 19

RECOVERY PERFORMANCE

TSXV:RLV ● FRA:6BX Relevium is leveraging the existing relationships of small, established brick and mortar distributor to seek commercial exclusivity of leading edge and innovative products

Specialty Performance and Wearables Distributor: Acquire a small local distribution company that targets innovative quality products on an exclusive basis from Europe and Asia. Leverage existing brick and mortar relationships and build E-Retail capabilities Exclusive Sourcing: Relevium has signed an exclusive cooperation agreement with Hong Kong based innovation group in wearable technology

*http://www.timetrade.com/files/TimeTrade_Consumer_Behavior_StateofRetail.pdf

DEVELOPING Brick & Mortar DISTRIBUTION CAPABILITIES: The fact that consumers will be spending $5 trillion in brick and-mortar by 2020 means that retailers have to be prepared to accommodate shoppers and their changing needs*

Investing in Active Lifestyles & Healthy Living

THE OPPORTUNITY

slide-20
SLIDE 20

RECOVERY PERFORMANCE

TSXV:RLV ● FRA:6BX Relevium has identified a sports equipment and wearable distribution company.

Revenues/Profits About $500K in revenues and projected to double this year. Most of the revenues arise from exclusive north American representation of high quality European sports equipment. Strategy: Leverage the company’s existing distribution to increase Relevium's brick and mortar distribution capabilities.

*http://www.reportlinker.com/p03517842-summary/Global-Sports-Equipment-Market.html

DEVELOPING Brick & Mortar DISTRIBUTION CAPABILITIES: The global sports equipment market is expected to grow at a CAGR of around 3%. The increased awareness of a healthy lifestyle is a key driver for the growth of this market and 46% of this is accounted by specialty retail shops*

Investing in Active Lifestyles & Healthy Living

THE OPPORTUNITY

slide-21
SLIDE 21

RECOVERY PERFORMANCE

TSXV:RLV ● FRA:6BX

Relevium plans to consolidate Physiotherapy clinics in key urban centers through the delivery of a new model for Health and Wellbeing.

Targets for 2016 include: Develop Pilot Relevium Wellness Clinic: In partnership with the Sports Performance Center, Relevium will develop a unique system for the delivery of Pain, Recovery and Performance services Integrate Leading Edge Technology: Relevium will introduce leading edge technologies to support its wellness system in addition to POS systems for managing customers service and business operations

*http://www.forbes.com/sites/thehartmangroup/2015/11/19/consumer-trends-in-health-and-wellness/#1064e9a14be7 *http://www.collegept.org/Assets/Website/Resources%20-%20Other/Trends_in_Physiotherapy_Ontario_2014.pdf

CONSOLIDATING PHYSIOTHERAPY AND WELLNESS: Progressive consumers are the window on to the future and growth

  • f Health and Wellness. The most recent changes in consumer attitudes, healthcare payment models and a more active aging

population are disrupting the physiotherapist’s business model and scope of practice*

Investing in Active Lifestyles & Healthy Living

THE OPPORTUNITY

slide-22
SLIDE 22

RECOVERY PERFORMANCE

TSXV:RLV ● FRA:6BX

Relevium Is currently developing the new Relevium Wellness System, a leading edge concept delivering physiotherapy and comprehensive wellness services. Relevium has identified a well-known clinic in Montreal to acquire its clientele and integrate into its pilot clinic, which is expected to launch in fall

  • f this year.

Revenues/Profits: About $700K in revenues from the pilot clinic with net profits of approximately 20%. Strategy: Use of leading-edge technology with Physiotherapy, Podiatry, Orthopedic Medicine, Functional Training, Acupuncture, Chiropractic, Osteopathy, Aqua-therapy and Recovery Yoga.

*http://www.forbes.com/sites/thehartmangroup/2015/11/19/consumer-trends-in-health-and-wellness/#1064e9a14be7 *http://www.collegept.org/Assets/Website/Resources%20-%20Other/Trends_in_Physiotherapy_Ontario_2014.pdf

CONSOLIDATING PHYSIOTHERAPY AND WELLNESS: Progressive consumers are the window on to the future and growth

  • f Health and Wellness. The most recent changes in consumer attitudes, healthcare payment models and a more active aging

population are disrupting the physiotherapist’s business model and scope of practice*

Investing in Active Lifestyles & Healthy Living

THE OPPORTUNITY

slide-23
SLIDE 23

About our Company FINANCIALS

slide-24
SLIDE 24

FINANCING

Capital Structure Snapshot

TSXV:RLV ● FRA:6BX

Stock Price: 0.10 36-Week Trading: 0.06-0.20 As As at: April 18, 2016

Trading Information

Insiders: 13,735,500 Escrowed: 11,362,500

Insider Holdings

Sector: Consumer Healthcare TSXV: RLV FRA: 6BX

General Information

Basic Shares O/S: 29,525,966 Stock Options: 3,161,511 Warrants: 10,015,466 F.D Shares O/S: 42,702,943

Capital Structure

slide-25
SLIDE 25

FINANCIALS

Build Revenue Base and Create Value

TSXV:RLV ● FRA:6BX

Builds critical mass and branding capabilities

Wellness E-Retail

Disruptive service offering and consolidation strategy

Wellness Clinics

Establishes brick and mortar retail distribution

B&M Distribution

Pain Management, Recovery and Performance

slide-26
SLIDE 26

FINANCIALS

Build Revenue Base and Create Value

TSXV:RLV ● FRA:6BX

QUALIFYING TRX Intellectual property for Pain and Recovery DISTRIBUTION Acquire existing distributor with established accounts WELLNESS CLINICS New Physiotherapy and Wellness System and consolidate the space E-RETAIL ASSETS Acquire e-retail assets for critical mass and branding No Revenues 600k-1M$ 2-10M$ 600k-1M

2017 2016

Initial accretive acquisition of E-Retail assets and B&M Distribution positions the company for immediate value creation and sets the stage for a larger acquisitions and wellness service offerings.

slide-27
SLIDE 27

FINANCIALS

Pro-forma Profit & Loss

Financially and strategically accretive acquisitions position the Company for growth TSXV:RLV ● FRA:6BX

Revenues: $2.7M

  • G. Profit : $1.9M

Earnings: $150K EBITDA: $190K Revenues: NIL

  • G. Profit: NIL

Earnings: -$650K EBITDA: -$612K Relevium Distribution Nutraceutical Relevium Consolidated

Note: This pro-forma statement is presented for illustrative purposes only and is not indicative of the results of

  • perations that might occur in the eventual acquisition or merger with identified targets or that may be expected to occur

in the future.

slide-28
SLIDE 28

About our Company INVESTMENT CONSIDERATION

slide-29
SLIDE 29

INVESTMENT HIGHLIGHTS

TSXV:RLV ● FRA:6BX

EXPERIENCED MANAGEMENT CONSOLIDATION STRATEGY GROWING WELLNESS MARKET E-COMMERCE FOCUSED CAPITAL STRUCTURE INNOVATION BASED

slide-30
SLIDE 30

About our Company WWW.RELEVIUMTECHNOLOGIES.COM

INFO@RELEVIUMTECHNOLOGIES.COM